the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy
NCT ID: NCT01045486
Last Updated: 2011-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
36 participants
INTERVENTIONAL
2010-01-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to determine whether probiotics is effective in the treatment of atopic dermatitis with cow milk allergy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotics in the Atopic Dermatitis
NCT01224132
Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children
NCT05443490
Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
NCT02519556
Protopic Adherence and Efficacy in Korean Eczema Patient
NCT02126176
An Innovative Probiotic Product With Antiallergic Properties
NCT04738565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Group A received active medication (ATP mixed probiotics) for 6 weeks followed by a crossover to 6 weeks of placebo after 4-weeks washout period.
ATP mixed probiotics
\- Patients in Group A will receive ATP mixed probiotics for 6 weeks. And after 4 weeks wash-out period, they will receive placebo for 6 weeks
Group B
Group B received placebo medication for 6 weeks followed by a crossover to 6 weeks of active medication (ATP mixed probiotics) after 4-weeks washout period.
Placebo
\- Patients in Group B will receive placebo for 6 weeks. And after 4 weeks wash-out period, they will receive ATP mixed probiotics for 6 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ATP mixed probiotics
\- Patients in Group A will receive ATP mixed probiotics for 6 weeks. And after 4 weeks wash-out period, they will receive placebo for 6 weeks
Placebo
\- Patients in Group B will receive placebo for 6 weeks. And after 4 weeks wash-out period, they will receive ATP mixed probiotics for 6 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to moderate atopic dermatitis with cow milk allergy
* Volunteers who agreed by their parents.
* The severity of their disease was assessed by modified SCORAD index
Exclusion Criteria
* Patients on systemic steroids, immune-suppression or Korean herbal medicine during the previous 6 weeks
* Anaphylaxis, Angioedema, or severe allergic reaction to the cow milk
* Chronic diarrhea
6 Months
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soonchunhyang University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pediatric Allergy & Respiratory Center, Soonchunhyang University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bok Yang Pyun
Role: STUDY_CHAIR
Pediatric Allergy & Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
schprobiotics
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.